I would like SANTO to become a well-known trademark around the world. So that we are proud of the fact that this is a Kazakhstani pharmaceutical brand.
Jiri Urbanec
CEO of SANTO
193,8
mln.
ampoules with injection solutions
2,6
mln.
bags and bottles with infusion solutions
7,7
mln.
vials with liquid oral medicinal products
14
mln.
powder antibiotics (penems/mycins)
35,4
mln.
powder antibiotics (cephalosporins)
518
mln.
tables produced by direct compression
135
tons of
tablet mass, using wet granulation technology

About us

SANTO is part of the international pharmaceutical group Polpharma, operating in the markets of Central and Eastern Europe, the Caucasus and Central Asia. The company develops, manufactures and supplies affordable medicines of high quality to the markets of Kazakhstan and Central Asia.

SANTO is the leader in the pharmaceutical market in Kazakhstan with a portfolio of more than 240 generic drugs in 12 pharmacotherapeutic groups for the treatment of diseases in various fields of therapy.

Currently, the Company is implementing the largest investment project to modernize existing pharmaceutical production facilities in accordance with international GMP standards, the volume of which is about USD 108 million.

The history of the company's creation
1882
Plant establishment
The SANTO plant was founded in 1882 by merchants Ivanov and Savenkov and produced the drug "Santonin" based on wormwood, a sprig of which is depicted on the coat of arms of the city of Shymkent.

1917
The largest manufacturer of pharmaceutical raw materials
During the Soviet period, the plant was the largest manufacturer of pharmaceutical substances from plant raw materials and the only manufacturer of narcotic substances.

1993
Reorganization into Chimpharm JSC
In 1993, the plant was transformed into a joint-stock company "Himpharm" and begins to develop ready-made dosage forms.

2011
Merger into Polpharma Group of Companies
In 2011, JSC "Himpharm" joins the international pharmaceutical group of companies Polpharma and begins a large-scale investment project at the SANTO plant to modernize production in accordance with the international pharmaceutical quality standard of Good Manufacturing Practice (GMP). The cost of the investment program is more than 108 million US dollars.

2014
Opening of a workshop for the production of ampoules and infusions (GMP)
Within the framework of the FIIR State Program, a workshop for the production of ampoules and infusions and the production of parenteral solutions of large and small dosages has been launched, which has no analog in the Eurasian region.

2016
Opening of a workshop for the production of antibiotic powders (GMP)
During the visit, President of the Republic of Kazakhstan Nursultan Nazarbayev opened new production lines of the SANTO company and got acquainted with the work of infusion lines in the shop for the production of ampoules and infusions. The infusion lines opened by the Head of State have no analogues both on the territory of the Republic of Kazakhstan and throughout Central Asia.

2017
Opening of the workshop of solid oral medicines (GMP)
On December 6, the Annual National Teleconference "New Industrialization of the country: The Leap of the Kazakh leopard" was held with the participation of the First President of the Republic of Kazakhstan, during which the production of solid oral medicines was launched at the largest pharmaceutical plant SANTO. The opening of the new production took place on the eve of the celebration of the 135th anniversary of the plant, symbolizing new prospects and horizons opening up before the flagship of the pharmaceutical industry of Kazakhstan.

2018
The opening of the oral liquid medicines workshop and the modernization of the warehouse (GMP and GDP)has been completed
The SANTO company continues to modernize its production and has launched a workshop for oral liquid medicines, passed GMP recertification and received a certificate for a modernized warehouse certificate of compliance with the standard of good distribution practice (GDP).

2019
Launch of a production site for the production of solid dosage forms by wet granulation (GMP), the opening of the sculpture "Look into the Future" and a digital engineering and educational center
On July 1, the SANTA plant hosted a solemn opening ceremony of a digital engineering and educational center and a sculpture "Looking into the Future", unique for the entire pharmaceutical industry of Kazakhstan, and a production site for the production of solid dosage forms by wet granulation was launched.

Our mission and values

Help people to be healthy, feel better, do more and live longer.
Уважение
Appreciation
Сотрудничество
Fairness
Ответственность
Responsibility
Солидарность
Solidarity
Сотрудничество
Collaboration

Career opportunities with SANTO

We are happy to bring into our large family the specialists with high potential and desire to contribute to development of our company.
SANTO’s representative offices in other countries

SANTO’s life

Opening of the Digital Engineering and Educational Center SANTO
                                   Watch
Opening of the sculpture " A Look into the future”
Watch
LISTEN TO YOUR HEART
Watch
Republican competition among sculptors "Code of Science and Art"
Watch
Opening of the workshop of solid oral medicines
Watch
Pulse of life
Watch
Seminar on Insurance medicine
Watch